TRIGONOMETRY101 

News, Information,

Resources, Sales

 

  Exact Time

 

 

 

  

 

Custom Search

 

   TRIGONOMETRY101 Custom Search on Anything! - Try it now!
  Get a job today!  1000s of Jobs!   Click on any job:  
 

Mainframes Jobs

z/OS, DB2, CICS, ECM

COBOL, SysProg, ASM,

Proj Mgrs, QA, Support

Software101 Jobs

JAVA, .NET, C++, C#

HTML, PHP, SQL, Linux

Internet, Web dev

 FIRE101 Jobs

Firemen, Volunteer,

EMT, EMS, Emergency,

Firefighters, Chief

 POLICE101 Jobs

Police Officers, Cops

Law Enforcement,

Paralegal, Forensics

 GENETICS101 Jobs

Lab Techs, Interns,

Genetics Research, Medical

Genetics Counselor, Biotech

 Nursing101 Jobs

Clinical, Emergency, ICU

LPN, RN, Travel, Home

Nurse Practitioners

 

  

 

 

 

 

    * Latest "Endpoints" News * 

 

Novartis hands off 3 preclinical programs to the antiviral R&D masters at Gilead  Endpoints News

The big biotech today snapped up 3 preclinical antiviral programs from pharma giant Novartis, with drugs promising to treat human rhinovirus, influenza and ...

On a hot streak, Novartis execs run the odds on their two most important PhIII readouts. Which is 0.01% more likely to succeed?  Endpoints News

Unlock this story instantly and join 55,100+ biopharma pros reading Endpoints daily — and it's free. SUBSCRIBE SIGN IN. Norbert Bischofberger. Kronos.

As Acthar troubles persist, Mallinckrodt invests in RNAi and Silence Therapeutics  Endpoints News

As part of the agreement, Mallinckrodt is getting an exclusive global license to Silence's C33 complement asset, SLN500, as well as options to license up to two ...

Medicxi is rolling out its biggest fund ever to back Europe's top 'scientists with strange ideas'  Endpoints News

Unlock this story instantly and join 55,000+ biopharma pros reading Endpoints daily — and it's free. SUBSCRIBE SIGN IN. Norbert Bischofberger. Kronos.

FDA contributes to hunt for new heart failure endpoints  FierceBiotech

A collaboration involving the FDA is set to evaluate new endpoints for heart failure clinical trials. The partners will use wearable devices to assess how heart ...

On a global romp, Boehringer BD team picks up its third R&D alliance for July — this time focused on IPF with $50M upfront  Endpoints News

Unlock this story instantly and join 55,000+ biopharma pros reading Endpoints daily — and it's free. SUBSCRIBE SIGN IN. Daniel O'Day. July 19, 2019 09:09 ...

The $1.1M goodbye: Gilead CSO John McHutchison is out as Daniel O'Day shakes up the senior team  Endpoints News

Unlock this story instantly and join 55,000+ biopharma pros reading Endpoints daily — and it's free. SUBSCRIBE SIGN IN. July 18, 2019 08:51 AM EDT.

Servier scoots out of another collaboration with MacroGenics, writing off their $40M  Endpoints News

Servier is walking out on a partnership with MacroGenics $MGNX — for the second time. After the market closed on Wednesday MacroGenics put out word that ...

Takeda preps another drug auction as execs look to further trim its post-Shire buyout debt load — report  Endpoints News

Backed by some of the biggest names in biotech, Norbert Bischofberger gets his megaround for platform tech out of MIT. A little over a year ago when I reported ...

AM-Pharma gathers €116M for PhIII program on kidney drug Pfizer passed on  Endpoints News

Back in 2015, Pfizer put a spotlight on Dutch biotech AM-Pharma and its drug candidate for sepsis-associated acute kidney injury, anteing up $87.5 million for a ...

Who's the toughest on drug prices? A game of political one-upmanship is driving the policy debate in Washington  Endpoints News

Trump, meanwhile, has everyone guessing about what he means by a “most favored nation” clause, but he's heaped just about every kind of abuse possible on ...

Eton Pharma handed CRL for reformulated conjunctivitis eye drop  Endpoints News

“If approved, EM-100 will be the first preservative-free allergy eye drop available in the United States and will allow us to better serve the millions of Americans ...

Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups  Endpoints News

Peter Kolchinsky and Raj Shah have another $300 million-plus to play with on the biotech venture side of their investment business. The two announced ...

Astellas buys into Frequency's regenerative med strategy with a $625M alliance on hearing loss  Endpoints News

Unlock this story instantly and join 55,000+ biopharma pros reading Endpoints daily — and it's free. SUBSCRIBE SIGN IN. July 19, 2019 10:48 AM EDT.

Going inside cells, Sung Joo Lee has sketched some big goals for his small — but global — team of drug hunters  Endpoints News

Unlock this story instantly and join 55,000+ biopharma pros reading Endpoints daily — and it's free. SUBSCRIBE SIGN IN. July 18, 2019 05:20 PM EDT.

     Internet Search Results 

  

 

 

 

TRIGONOMETRY101.COM --- Trigonometry Information, News, and Resources, Lots More
Need to Find information on any subject? ASK THE TRIGONOMETRY101 GURU! - Images from Wikipedia

 * Contact us:  support@z101.com
 
                                  

Copyright � 2007-2013  TRIGONOMETRY101.COM